{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:43:45Z","timestamp":1767851025264,"version":"3.49.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T00:00:00Z","timestamp":1700870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,28]]},"abstract":"<jats:p>Invasive meningococcal disease (IMD) is rare in travellers but associated with high mortality and long-term sequelae. Six serogroups (MenABCWXY) account for more than 90% of IMD. Three pentavalent vaccines are on the horizon: two MenABCWY, both with a 0\u20136\u00a0month schedule, highly immunogenic and well tolerated, and one single-dose MenACWXY.<\/jats:p>","DOI":"10.1093\/jtm\/taad152","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T14:19:01Z","timestamp":1700921941000},"source":"Crossref","is-referenced-by-count":5,"title":["Three novel pentavalent meningococcal vaccines"],"prefix":"10.1093","volume":"31","author":[{"given":"Robert","family":"Steffen","sequence":"first","affiliation":[{"name":"Epidemiology , Biostatistics and Prevention Institute, Department of Public and Global Health, Division of Infectious Diseases, World Health Organization Collaborating Centre for Travelers\u2019 Health, , Zurich , Switzerland"},{"name":"University of Zurich , Biostatistics and Prevention Institute, Department of Public and Global Health, Division of Infectious Diseases, World Health Organization Collaborating Centre for Travelers\u2019 Health, , Zurich , Switzerland"},{"name":"Division of Epidemiology , Human Genetics & Environmental Sciences, , Houston, TX , USA"},{"name":"University of Texas School of Public Health , Human Genetics & Environmental Sciences, , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Caumes","sequence":"additional","affiliation":[{"name":"Infectious and Tropical Diseases, Sorbonne University , Paris , France"},{"name":"Centre de diagnostic et de th\u00e9rapeutique, H\u00f4pital de l\u2019H\u00f4tel-Dieu. , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,11,25]]},"reference":[{"key":"2024012910331143000_ref1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/14760584.2019.1557520","article-title":"The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations","volume":"18","author":"Acevedo","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"2024012910331143000_ref2","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2023.102581","article-title":"Carriage of Neisseria meningitidis among travelers attending the Hajj pilgrimage, circulating serogroups, sequence types and antimicrobial susceptibility: a multinational longitudinal cohort study","volume":"53","author":"Yezli","year":"2023","journal-title":"Travel Med Infect Dis"},{"key":"2024012910331143000_ref3","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1007\/s12325-022-02149-7","article-title":"One-year sequelae and quality of life in adults with meningococcal meningitis: lessons from the COMBAT Multicentre Prospective Study","volume":"39","author":"Duval","year":"2022","journal-title":"Adv Ther"},{"key":"2024012910331143000_ref4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/vaccines10040617","article-title":"Efficacy and effectiveness of the meningococcal conjugate Group A vaccine MenAfriVac\u00ae in preventing recurrent meningitis epidemics in Sub-Saharan Africa","volume":"10","author":"Viviani","year":"2022","journal-title":"Vaccine"},{"key":"2024012910331143000_ref5","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S1473-3099(23)00191-3","article-title":"Immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: an observer-blind, active-controlled, randomized trial","volume":"23","author":"Peterson","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2024012910331143000_ref6","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1056\/NEJMoa2214924","article-title":"Meningococcal ACWYX conjugate vaccine in 2-to-29-year-olds in Mali and Gambia","volume":"388","author":"Haidara","year":"2023","journal-title":"N Engl J Med"},{"key":"2024012910331143000_ref7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1708-8305.2010.00449.x","article-title":"The risk of meningococcal disease in travelers and current recommendations for prevention","volume":"17","author":"Steffen","year":"2010","journal-title":"J Travel Med"},{"key":"2024012910331143000_ref8","article-title":"Travel-related infections presenting in Europe: a 20-year analysis of EuroTravNet surveillance data","volume":"1","author":"Grobusch","year":"2020","journal-title":"Lancet Reg Health Eur"},{"key":"2024012910331143000_ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1708-8305.2009.00361.x","article-title":"Travel-related cerebro-meningeal infections: the 8-year experience of a French infectious disease unit","volume":"17","author":"Rapp","year":"2010","journal-title":"J Travel Med"},{"key":"2024012910331143000_ref10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s40121-019-00262-9","article-title":"Incidence and prevention of invasive meningococcal disease in global mass gathering events","volume":"8","author":"Muttalif","year":"2019","journal-title":"Infect Dis Ther"},{"key":"2024012910331143000_ref11","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taad085","article-title":"Travel vaccines \u2014 priorities determined by incidence and impact","volume":"30","author":"Steffen","year":"2023","journal-title":"J Travel Med"},{"key":"2024012910331143000_ref12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2807\/1560-7917.ES.2016.21.5.30122","article-title":"Evaluation of a temporary vaccination recommendation in response to an outbreak of invasive meningococcal serogroup C disease in men who have sex with men in Berlin, 2013-2014","volume":"21","author":"Koch","year":"2016","journal-title":"Euro Surveill"}],"container-title":["Journal of Travel Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jtm\/advance-article-pdf\/doi\/10.1093\/jtm\/taad152\/54705267\/taad152.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jtm\/article-pdf\/31\/1\/taad152\/56439763\/taad152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jtm\/article-pdf\/31\/1\/taad152\/56439763\/taad152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T10:33:34Z","timestamp":1706524414000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jtm\/article\/doi\/10.1093\/jtm\/taad152\/7451060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,25]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,11,25]]},"published-print":{"date-parts":[[2024,1,28]]}},"URL":"https:\/\/doi.org\/10.1093\/jtm\/taad152","relation":{},"ISSN":["1195-1982","1708-8305"],"issn-type":[{"value":"1195-1982","type":"print"},{"value":"1708-8305","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1]]},"published":{"date-parts":[[2023,11,25]]},"article-number":"taad152"}}